drugset / Trial / NCT02689999

The Effect of Dexrabeprazole on Intragastric and Intraesophageal Acidity

NCT02689999 ↗

Phase 4 Completed 12 enrolled Neutec Ar-Ge San ve Tic A.Ş
NaSingle-groupOpen-labelTreatment

Summary

It is planned to investigate the effect of dexrabeprazole on gastric acid primarily, and then gastroesophageal reflux disease (GERD) symptoms, intraesophageal acidity (reflux) and impedance kinetics.

Timeline

Start
2016-02
Primary completion
2017-05
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexrabeprazole Small molecule 10 mg —